Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FvIjpGLVT5lFfsKq3ChwjGKl8UX4.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version 2.10.0, adding 5 more interventions/treatments and 2 more study numbers, while removing the previous version 2.9.7.SummaryDifference0.4%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check16 days agoChange DetectedThe website now displays the actual last update posted instead of an estimated time, providing users with more accurate information.SummaryDifference0.0%
- Check17 days agoChange DetectedA new treatment regimen involving Pembrolizumab, Pemetrexed, and Platinum Chemotherapy has been added, with specific dosing and administration details provided. Additionally, the definition and monitoring of adverse events, as well as the criteria for disease progression assessment, have been updated and presented.SummaryDifference10%
- Check24 days agoChange DetectedThe value of the publication has been updated to include a new DOI number: doi: 10.1016/j.lungcan.2023.107285.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.